UTMD PE Ratio & Valuation, Is UTMD Overvalued

Historical Valuation

Utah Medical Products Inc (UTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Utah Medical Products Inc (UTMD) is between -- to -- according to relative valuation method.

Relative Value

Fair Zone

-----

Current Price：63.78

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Utah Medical Products Inc (UTMD) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Utah Medical Products Inc (UTMD) has a current Price-to-Book (P/B) ratio of 1.53. Compared to its 3-year average P/B ratio of 2.04, the current P/B ratio is approximately -24.98% higher. Relative to its 5-year average P/B ratio of 2.46, the current P/B ratio is about -37.80% higher. Utah Medical Products Inc (UTMD) has a Forward Free Cash Flow (FCF) yield of approximately 7.67%. Compared to its 3-year average FCF yield of 6.87%, the current FCF yield is approximately 11.65% lower. Relative to its 5-year average FCF yield of 6.57%, the current FCF yield is about 16.68% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for UTMD competitors is 3.52, providing a benchmark for relative valuation. Utah Medical Products Inc Corp (UTMD.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of -1.93%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of UTMD increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of UTMD in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is UTMD currently overvalued or undervalued?

What is Utah Medical Products Inc (UTMD) fair value?

UTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Utah Medical Products Inc (UTMD) is between to according to relative valuation method.

How does UTMD's valuation metrics compare to the industry average?

The average P/S ratio for UTMD's competitors is 3.52, providing a benchmark for relative valuation. Utah Medical Products Inc Corp (UTMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -1.93%, this premium appears unsustainable.

What is the current P/B ratio for Utah Medical Products Inc (UTMD) as of Mar 12 2026?

As of Mar 12 2026, Utah Medical Products Inc (UTMD) has a P/B ratio of 1.53. This indicates that the market values UTMD at 1.53 times its book value.

What is the current FCF Yield for Utah Medical Products Inc (UTMD) as of Mar 12 2026?

As of Mar 12 2026, Utah Medical Products Inc (UTMD) has a FCF Yield of 7.67%. This means that for every dollar of Utah Medical Products Inc's market capitalization, the company generates 7.67 cents in free cash flow.

What is the current Forward P/E ratio for Utah Medical Products Inc (UTMD) as of Mar 12 2026?

As of Mar 12 2026, Utah Medical Products Inc (UTMD) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Utah Medical Products Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Utah Medical Products Inc (UTMD) as of Mar 12 2026?

As of Mar 12 2026, Utah Medical Products Inc (UTMD) has a Forward P/S ratio of 0.00. This means the market is valuing UTMD at $0.00 for every dollar of expected revenue over the next 12 months.

UTMD Valuation